SK Life Science, Inc. Presents XCOPRI® (cenobamate tablets) CV Data at the AES 2024 Annual Meeting Showing a Deeper Understanding of Cenobamate’s Dual Mechanism of Action
PARAMUS, N.J., Dec. 8, 2024 /PRNewswire/ — SK Life Science, Inc., a global leader in treatments for central…